IMS Health South Africa
Address: Office 101, 1st Floor
The Piazza, Melrose Arch
Tel: +27 (0)11 380 5200
The demand for reliable market intelligence and accountability in global healthcare has never been greater. From researchers and payers to government agencies and pharmaceutical manufacturers, healthcare stakeholders need to better understand the role prescription drugs play in delivering high-quality, cost-effective care. At the same time, pharmaceutical companies face unprecedented competition for market share and pressures to maximize brand lifecycles, all while proving the value of their medicines.
In today’s complex healthcare marketplace, a growing set of audiences depend on IMS to yield the most accurate perspective of global market dynamics.
Organizing a vast array of healthcare data and facts into solid, relevant metrics to help answer key questions is an enormous undertaking. IMS can apply insight and capabilities to a tremendously rich set of data assets and analytics. We are the gold standard in pharmaceutical and healthcare market intelligence, relied on by virtually all of the world’s largest pharmaceutical and biotech companies — along with government agencies, policymakers, researchers and financial analysts around the globe.
Our end-to-end solutions — integrating unparalleled information, analytics, consulting and services — play a central role in supporting high-quality, cost-effective healthcare. Our people bring the facts and figures to life, leveraging our extensive global network and expertise.
Products and services
At the heart of it all: our unmatched global information assets. We process billions of healthcare transactions each year, covering nearly every world market. The information we gather and refine ensures a deep understanding of the marketplace — examining market share, sales volumes, pricing patterns, prescriber attitudes, promotional effectiveness and more.
To ensure the highest accuracy, IMS draws on a range of data sources unparalleled in the industry — from drug manufacturers, wholesalers and retail pharmacies to hospitals, long-term care facilities and healthcare professionals — in more than 100 countries.
We’re the only company that tracks more than 70 percent of global pharmaceutical sales — including more than 90 percent of sales and 70 percent of dispensed prescriptions in the U.S. alone.
We also capture information about more than 260 million anonymized patients worldwide, including their diagnosis and treatment. These unprecedented views into prescribing and treatment patterns play a central role in managing and measuring the quality and cost efficiency of healthcare — and assessing the role medicines play in advancing global health.
Flexible, Sophisticated Analytics
Drawing on our own data and other key sources, IMS analytics transform information into actionable intelligence. Our analytics discern and identify patterns, establish benchmarks, provide forecasts, test assumptions, and evaluate programs. They apply dynamic algorithms and custom methodologies to derive insights from data, trends and attitudes in markets worldwide. Our deep knowledge of the industry enables us to apply the right business assumptions to create analytics that deliver the most relevant answers.
Applying our powerful combination of information and analytics, IMS consultants deliver evidence-based recommendations that help clients reshape their business and brands to achieve greater success. Our Consulting and Services teams include thought leaders, with expertise in industry issues, business processes, and therapies — at the global, regional and local levels. We interpret information, analyze risks and uncover opportunities.